Showing results (121-130 of 191) with videos related to
Sort By:
Pageof 20
Oncogene|August 20, 2020
A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27Dehai Wu, Yan Wang, Guangchao Yang, et al.Nature Cell Biology|February 12, 2026
THY1+ cancer stem cells drive metastasis through a pseudohypoxic state shaped by neutrophil-derived mitochondriaWen-Hua Wan, Pei-Lin Li, Wen-Jie Cao, et al.Cell|July 16, 2025
Glucose restriction shapes pre-metastatic innate immune landscapes in the lung through exosomal TRAILCai-Yuan Wu, Chun-Xiang Huang, Xiang-Ming Lao, et al.Journal of Advanced Research|February 25, 2024
HnRNPR-mediated UPF3B mRNA splicing drives hepatocellular carcinoma metastasisHong Wang, Dong Qian, Jiabei Wang, et al.Molecular Cancer|November 8, 2019
ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasisQiushi Lin, Xuesong Chen, Fanzheng Meng, et al.Science Bulletin|April 17, 2026
Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axisMengya Geng, Fanzheng Meng, Hairui Li, et al.Oncogene|December 6, 2022
Targeting SLP2-mediated lipid metabolism reprograming restricts proliferation and metastasis of hepatocellular carcinoma and promotes sensitivity to LenvatinibYufeng Liu, Linmao Sun, Hongrui Guo, et al.Cell Death & Disease|April 28, 2018
PGC1α promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC1 expression to reverse the Warburg effectDan Li, Chaoqun Wang, Panfei Ma, et al.Cancer Research|September 28, 2021
A PLCB1-PI3K-AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma ProgressionShuhang Liang, Hongrui Guo, Kun Ma, et al.Molecular Cancer|May 17, 2018
Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferationXirui Liu, Yingjian Liang, Ruipeng Song, et al.Pageof 20